Exact Sciences Corp. (EXAS) Social Stream
EXACT SCIENCES CORP (EXAS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering EXACT SCIENCES CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 13 | $165 | $95 | $143.583 | $65.38 | 119.61% |
| 2021-12-08 | 13 | $163 | $95 | $140.25 | $65.38 | 114.52% |
| 2022-01-04 | 13 | $163 | $95 | $139.25 | $65.38 | 112.99% |
| 2022-01-06 | 13 | $163 | $95 | $138 | $65.38 | 111.07% |
| 2022-01-18 | 12 | $163 | $95 | $136.5 | $65.38 | 108.78% |
| 2022-02-23 | 12 | $160 | $90 | $130.454 | $65.38 | 99.53% |
| 2022-02-24 | 12 | $160 | $90 | $125 | $65.38 | 91.19% |
| 2022-04-26 | 12 | $160 | $90 | $124.09 | $65.38 | 89.8% |
| 2022-04-28 | 11 | $160 | $65 | $104.714 | $65.38 | 60.16% |
| 2022-06-03 | 12 | $160 | $50 | $98.4 | $65.38 | 50.5% |
| 2022-07-19 | 9 | $95 | $50 | $79.083 | $65.38 | 20.96% |
| 2022-08-03 | 12 | $95 | $50 | $79.083 | $65.38 | 20.96% |
| 2022-08-13 | 13 | $95 | $50 | $71.307 | $65.38 | 9.07% |
| 2022-09-17 | 13 | $95 | $40 | $70.538 | $65.38 | 7.89% |
| 2022-10-17 | 13 | $95 | $40 | $69 | $65.38 | 5.54% |
| 2022-10-24 | 13 | $95 | $40 | $69.75 | $65.38 | 6.68% |
| 2022-11-04 | 13 | $85 | $40 | $65.363 | $65.38 | -0.03% |
| 2022-11-07 | 13 | $85 | $35 | $63.545 | $65.38 | -2.81% |
| 2022-11-08 | 13 | $85 | $35 | $62.636 | $65.38 | -4.2% |
| 2022-11-14 | 13 | $85 | $35 | $62 | $65.38 | -5.17% |
| 2022-12-04 | 13 | $85 | $35 | $61.09 | $65.38 | -6.56% |
| 2022-12-15 | 12 | $85 | $35 | $61.09 | $65.38 | -6.56% |
| 2023-01-06 | 12 | $85 | $35 | $62.545 | $65.38 | -4.34% |
| 2023-01-12 | 12 | $85 | $35 | $61.545 | $65.38 | -5.87% |
| 2023-02-08 | 12 | $85 | $35 | $63.181 | $65.38 | -3.36% |
| 2023-02-21 | 13 | $85 | $35 | $63.181 | $65.38 | -3.36% |
| 2023-02-23 | 13 | $92 | $50 | $74.166 | $65.38 | 13.44% |
| 2023-03-03 | 13 | $92 | $55 | $75.833 | $65.38 | 15.99% |
| 2023-03-09 | 13 | $92 | $55 | $77.5 | $65.38 | 18.54% |
| 2023-04-21 | 14 | $92 | $55 | $76.818 | $65.38 | 17.49% |
| 2023-05-10 | 14 | $92 | $55 | $77.333 | $65.38 | 18.28% |
| 2023-05-11 | 14 | $99 | $70 | $84.916 | $65.38 | 29.88% |
| 2023-05-14 | 14 | $99 | $73 | $85.75 | $65.38 | 31.16% |
| 2023-06-06 | 14 | $95 | $73 | $87 | $65.38 | 33.07% |
| 2023-06-07 | 14 | $100 | $73 | $88.5 | $65.38 | 35.36% |
| 2023-06-20 | 15 | $120 | $73 | $91 | $65.38 | 39.19% |
| 2023-06-22 | 15 | $130 | $73 | $98.666 | $65.38 | 50.91% |
| 2023-06-23 | 15 | $130 | $73 | $103.384 | $65.38 | 58.13% |
| 2023-07-24 | 16 | $130 | $73 | $105.5 | $65.38 | 61.36% |
| 2023-08-01 | 16 | $130 | $73 | $105.5 | $65.38 | 61.36% |
| 2023-08-03 | 16 | $130 | $73 | $109.357 | $65.38 | 67.26% |
| 2023-08-08 | 16 | $130 | $73 | $110.071 | $65.38 | 68.36% |
| 2023-09-28 | 17 | $130 | $73 | $108.266 | $65.38 | 65.59% |
| 2023-10-10 | 17 | $130 | $73 | $108.266 | $65.38 | 65.59% |
| 2023-10-15 | 17 | $130 | $73 | $107.6 | $65.38 | 64.58% |
| 2023-10-20 | 17 | $130 | $73 | $106.133 | $65.38 | 62.33% |
| 2023-11-03 | 17 | $130 | $73 | $101.266 | $65.38 | 54.89% |
| 2023-11-06 | 17 | $130 | $73 | $100.6 | $65.38 | 53.87% |
The Trend in the Analyst Price Target
Over the past 43 months, EXAS's average price target has gone up $0.13.
EXAS reports an average of 17.95% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-23 | 13 | 92 | 50 | 74.166 | 61.63 | 20.34% |
| 2023-03-03 | 13 | 92 | 55 | 75.833 | 67.51 | 12.33% |
| 2023-05-15 | 14 | 95 | 73 | 87.000 | 80.93 | 7.5% |
| 2023-06-07 | 15 | 100 | 73 | 88.500 | 87.76 | 0.84% |
| 2023-11-03 | 17 | 130 | 73 | 102.466 | 67.02 | 52.89% |
EXAS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.35 | 14 | 0 | 3 | 0 | 0 | 17 |
The Trend in the Broker Recommendations
Over the past 15 months, EXAS's average broker recommendation rating improved by 0.03.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- EXACT SCIENCES CORP's number of analysts covering the stock is higher than 4320.52% of all US stocks.
- In the context of Healthcare stocks, EXACT SCIENCES CORP's average analyst price target is higher than 4560% of them.
- EXAS has a higher upside potential (average analyst target price relative to current price) than 3472.91% of stocks in the large market cap category.
- EXAS has a lower variance in analysts' estimates than -3892.46% of stocks in the large market cap category.
Stocks similar to EXACT SCIENCES CORP in the Business Services industry regarding analyst recommendations and price targets are CRL, INCY, and WSC.
View All Top Stocks by Price Target
Is EXAS a Buy, Hold or Sell? See the POWR Ratings now!